JPS57156460A - Stabilized composition of prostaglandin and prostaglandin mimic compound, and its preparation - Google Patents
Stabilized composition of prostaglandin and prostaglandin mimic compound, and its preparationInfo
- Publication number
- JPS57156460A JPS57156460A JP3964081A JP3964081A JPS57156460A JP S57156460 A JPS57156460 A JP S57156460A JP 3964081 A JP3964081 A JP 3964081A JP 3964081 A JP3964081 A JP 3964081A JP S57156460 A JPS57156460 A JP S57156460A
- Authority
- JP
- Japan
- Prior art keywords
- prostaglandin
- mimic compound
- solution
- oligosaccharide
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003180 prostaglandins Chemical class 0.000 title abstract 9
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 230000003278 mimic effect Effects 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 3
- 125000003259 prostaglandin group Chemical group 0.000 title abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 7
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 5
- 150000004676 glycans Chemical class 0.000 abstract 3
- 229920001542 oligosaccharide Polymers 0.000 abstract 3
- 150000002482 oligosaccharides Chemical class 0.000 abstract 3
- 229920001282 polysaccharide Polymers 0.000 abstract 3
- 239000005017 polysaccharide Substances 0.000 abstract 3
- 239000000243 solution Substances 0.000 abstract 3
- 239000007864 aqueous solution Substances 0.000 abstract 2
- DZUXGQBLFALXCR-UHFFFAOYSA-N (+)-(9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprost-13-en-1-oic acid Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CCCCCCC(O)=O DZUXGQBLFALXCR-UHFFFAOYSA-N 0.000 abstract 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 abstract 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 abstract 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- 229920001202 Inulin Polymers 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 abstract 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 abstract 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 abstract 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 1
- 229940029339 inulin Drugs 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3964081A JPS57156460A (en) | 1981-03-20 | 1981-03-20 | Stabilized composition of prostaglandin and prostaglandin mimic compound, and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3964081A JPS57156460A (en) | 1981-03-20 | 1981-03-20 | Stabilized composition of prostaglandin and prostaglandin mimic compound, and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57156460A true JPS57156460A (en) | 1982-09-27 |
| JPS6152146B2 JPS6152146B2 (en, 2012) | 1986-11-12 |
Family
ID=12558683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3964081A Granted JPS57156460A (en) | 1981-03-20 | 1981-03-20 | Stabilized composition of prostaglandin and prostaglandin mimic compound, and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57156460A (en, 2012) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5818357A (ja) * | 1981-07-28 | 1983-02-02 | Ono Pharmaceut Co Ltd | ６，９−メタノ−ｐｇｉ↓２及び６，９−メタノ−ｐｇｉ↓２類似化合物の安定化組成物及びその製造方法 |
| JPS59148760A (ja) * | 1983-02-12 | 1984-08-25 | バイエル・アクチエンゲゼルシヤフト | プロスタグランジンの複合体 |
| DE4309579A1 (de) * | 1993-03-24 | 1994-09-29 | Sanol Arznei Schwarz Gmbh | Pharmazeutische Zusammensetzung in Form eines Kits |
| WO2005046699A1 (ja) * | 2003-11-13 | 2005-05-26 | Ono Pharmaceutical Co., Ltd. | プロスタグランジン含有凍結乾燥品 |
| JP2005272458A (ja) * | 2004-02-27 | 2005-10-06 | Ono Pharmaceut Co Ltd | 経口投与用医薬組成物 |
| JP2005314413A (ja) * | 2004-04-02 | 2005-11-10 | Ono Pharmaceut Co Ltd | 経口投与用医薬組成物 |
| WO2006075690A1 (ja) * | 2005-01-14 | 2006-07-20 | Ono Pharmaceutical Co., Ltd. | 安定な医薬組成物 |
| WO2008018592A1 (fr) * | 2006-08-11 | 2008-02-14 | Taisho Pharmaceutical Co., Ltd. | Préparation externe comprenant un dérivé de la prostaglandine |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2303451C2 (ru) | 2001-07-23 | 2007-07-27 | Оно Фармасьютикал Ко., Лтд. | Фармацевтические композиции для лечения заболеваний, связанных с уменьшением костной массы, включающие агонист ер4 в качестве активного ингредиента |
| JP4497320B2 (ja) | 2002-10-10 | 2010-07-07 | 小野薬品工業株式会社 | 内因性修復因子産生促進剤 |
| RU2452479C2 (ru) | 2007-02-16 | 2012-06-10 | Оно Фармасьютикал Ко., Лтд. | Терапевтический агент при нарушении мочевыделения |
| AU2008246579A1 (en) | 2007-05-08 | 2008-11-13 | National University Corporation, Hamamatsu University School Of Medicine | Cytotoxic T cell activator comprising EP4 agonist |
| PT2441760E (pt) | 2009-06-10 | 2014-01-07 | Ono Pharmaceutical Co | Composto com actividade de contracção muscular do detrusor e actividade de relaxação muscular do esfíncter uretral |
| JP4890657B1 (ja) * | 2011-06-03 | 2012-03-07 | 小野薬品工業株式会社 | リマプロストとβ−シクロデキストリンを含有する錠剤 |
| JP6052175B2 (ja) | 2011-08-02 | 2016-12-27 | 小野薬品工業株式会社 | 左室拡張機能改善剤 |
| RU2658823C2 (ru) | 2012-08-31 | 2018-06-25 | Оно Фармасьютикал Ко., Лтд. | Аминовая соль и ее кристаллы |
| JP6675653B2 (ja) | 2016-05-09 | 2020-04-01 | Ａｇｃ株式会社 | 新規なプロスタグランジン誘導体 |
-
1981
- 1981-03-20 JP JP3964081A patent/JPS57156460A/ja active Granted
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5818357A (ja) * | 1981-07-28 | 1983-02-02 | Ono Pharmaceut Co Ltd | ６，９−メタノ−ｐｇｉ↓２及び６，９−メタノ−ｐｇｉ↓２類似化合物の安定化組成物及びその製造方法 |
| JPS59148760A (ja) * | 1983-02-12 | 1984-08-25 | バイエル・アクチエンゲゼルシヤフト | プロスタグランジンの複合体 |
| DE4309579A1 (de) * | 1993-03-24 | 1994-09-29 | Sanol Arznei Schwarz Gmbh | Pharmazeutische Zusammensetzung in Form eines Kits |
| US5681855A (en) * | 1993-03-24 | 1997-10-28 | Schwarz Pharma Ag | PGE1 emulsion composition kit |
| DE4309579C3 (de) * | 1993-03-24 | 2000-01-27 | Sanol Arznei Schwarz Gmbh | Pharmazeutische Zusammensetzung in Form einer Packung |
| WO2005046699A1 (ja) * | 2003-11-13 | 2005-05-26 | Ono Pharmaceutical Co., Ltd. | プロスタグランジン含有凍結乾燥品 |
| KR100840164B1 (ko) * | 2003-11-13 | 2008-06-23 | 오노 야꾸힝 고교 가부시키가이샤 | 프로스타글란딘 함유 동결 건조품 |
| JP2005272458A (ja) * | 2004-02-27 | 2005-10-06 | Ono Pharmaceut Co Ltd | 経口投与用医薬組成物 |
| JP2005314413A (ja) * | 2004-04-02 | 2005-11-10 | Ono Pharmaceut Co Ltd | 経口投与用医薬組成物 |
| WO2006075690A1 (ja) * | 2005-01-14 | 2006-07-20 | Ono Pharmaceutical Co., Ltd. | 安定な医薬組成物 |
| WO2008018592A1 (fr) * | 2006-08-11 | 2008-02-14 | Taisho Pharmaceutical Co., Ltd. | Préparation externe comprenant un dérivé de la prostaglandine |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6152146B2 (en, 2012) | 1986-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS57156460A (en) | Stabilized composition of prostaglandin and prostaglandin mimic compound, and its preparation | |
| FI874351A0 (fi) | Kolhydratsiraper och foerfaranden foer framstaellning av dessa. | |
| DE3686945D1 (de) | Kaugummizusammensetzungen und deren herstellungsverfahren. | |
| KR870002842A (ko) | 싸이클로덱스트린으로 제조되는 7-이소프로폭시-이소플라본의 함유착물과 그를 활성성분으로 함유하는 약리학적 조성물 및 제제 | |
| JPS6485055A (en) | Method for manufacturing concentrate of sweeting agent and concentrate of sweeting agent having heat-stability | |
| EP0164656A3 (en) | Composition of gluco-oligosaccharide and process for its preparation | |
| CA2110386A1 (en) | Method for the Enzymatic Synthesis of Alpha-Sialylated Oligosaccharide Glycosides | |
| CA2209696A1 (fr) | Utilisation d'un polyholoside dans une composition destinee a stimuler les defenses immunitaires, et composition le comprenant | |
| EP0181166A3 (en) | Solubilised platinum compounds | |
| EP0213717A3 (en) | Iodophor containing suppository | |
| HUT65418A (en) | Process for producing inclusion compounds of nimesulide with cyclodextrins and pharmaceutical preparatives containing them | |
| AU571349B2 (en) | Membrane polysaccharides | |
| ZA906010B (en) | Process for the preparation of a sweetener based on aspartame | |
| Hirayama et al. | Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-β-cyclodextrins | |
| KR850007054A (ko) | 아세트알데히드 고정방법 | |
| JPS5642560A (en) | Preparation of water-soluble solid material of sweetener | |
| CA2066165A1 (en) | Wellbore fluid | |
| WO2002012388A3 (en) | Process for the production of chemically or enzymatically modified polysaccharides, and products made thereby | |
| JPS54103844A (en) | Method of stabilizing formulation of prostaglandin and its analogs | |
| DE69413467D1 (de) | Polyglucuronsäure als remittierendes Mittel für das nephrotische Syndrom und Symptome von Hepatopathie | |
| KR890011894A (ko) | 세팔로스포린 유도체를 안정화제로 건조시켜 안정화하는 방법 및 세팔로스포린 유도체를 함유하는 안정한 조성물 | |
| AU553594B2 (en) | Procedure of bonding roofbolt rods to bolt holes | |
| JPS574922A (en) | Agent for lowering ammonia in blood | |
| Abbott et al. | Studies on dextrans and dextranases. Part VIII. Size and distribution of branches in some dextrans | |
| Inoue et al. | Serotype specificity for some biochemical characteristics of Streptococcus mutans |